This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, Daiichi Sankyo Europe Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Shinko Hayashi: Innovator in Antibody Development
Introduction
Shinko Hayashi is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of novel antibodies.
Latest Patents
Hayashi holds a patent for a Human anti-FGFR4 antibody. This invention relates to innovative antibodies against the FGF receptor 4 (FGFR4) and their medical applications. The patent focuses on the diagnosis, prevention, or treatment of diseases associated with FGFR expression, overexpression, or hyperactivity. He has 1 patent to his name.
Career Highlights
Throughout his career, Shinko Hayashi has worked with notable companies in the pharmaceutical industry. He has been associated with Daiichi Sankyo Europe GmbH and Daiichi Sankyo Company, Limited. His work in these organizations has contributed to advancements in medical research and therapeutic development.
Collaborations
Hayashi has collaborated with esteemed colleagues, including Reimar Abraham and Keisuke Fukuchi. These partnerships have fostered innovation and progress in their respective fields.
Conclusion
Shinko Hayashi's work in antibody development showcases his dedication to advancing medical science. His contributions have the potential to impact the diagnosis and treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile